MACULAR DEGENERATION PROJECTOBJECTIVES The CJRC’s project aims to develop treatment for Macular Degeneration – an almost epidemic cause of blindness in our ageing population. The CJRC has been awarded 3 million dollars from the Clem Jones Foundation to engage specifically in research and development of treatments for Macular Degeneration. The objectives for this project, as listed below, are also amenable to any disease of the eye whereby retinal transplantation would treat blindness such as Retinitis pigmentosa. Specific Objectives:
1) Engineer artificial retinal biomimetic 3 dimensional scaffolds using nanotechnology 2) Design complex multilayered tissue by seeding stem cells into various scaffolds and subsequently combine several seeded scaffolds to make multilayered tissue that recapitulates the retina’s layered structure 3) Fine-tune the differentiation of adult stem cells within nano-woven membrane scaffolds to include native structures of the retina in the correct temporo-spatial organisation.
|
|
Clem Jones Research Centre for Stem Cells & Tissue Regenerative Therapies Phone: +61 7 559 51220
Fax: +61 7 559 54538
Email: Patrick H. Warnke, Dr. med.habil., Dr. med.dent.
Faculty of Health Sciences & Medicine, Level 4
Bond University | Gold Coast, Queensland, 4229, Australia
|
